Skip to Main Content

Moderna is moving at unprecedented speed to develop a vaccine to prevent infection from the novel coronavirus. But the biotech’s soaring stock price is moving faster, which raises an important question: Are investors taking on too much risk?

Since late February, Moderna shares have more than tripled in value — making it one of the top-performing biotech stocks this year. On Monday, shares hit an all-time high of $66.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED
  • I used to subscribe to your service when you were at the street
    Since then I have bee out of biotech
    But I am considering getting back in
    Before I subscribe I would be interested in your comments Radius Rdus . Prior to 17 I sold at 55 but now it’s in the low teens ????
    Thank you

Comments are closed.